Small change, big difference: A novel praziquantel derivative P96 with multistage antischistosomal activity for chemotherapy of schistosomiasis japonica
J. Xu, L.-L. Dong, H. Sun, P. Huang, R.-Z. Zhang, X.-Y. Wang, D.-Q. Sun, C.-M. Xia
This paper introduces a novel praziquantel derivative, P96, which shows improved antischistosomal activity against all developmental stages of Schistosoma japonicum compared to praziquantel.
bioRxiv · Mar 6, 2023 · PreprintPharmacology & Toxicology